Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-12-20
1987-11-03
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 67, 546 68, 546 69, A61K 3148, C07D45704
Patent
active
047043962
ABSTRACT:
Phenacyl or substituted phenacyl esters of 1-substituted-6-C.sub.1-4 straight chain alkyl (or allyl)ergoline-8.beta.-carboxylic acid, useful as 5HT receptor antagonists.
REFERENCES:
patent: 3113133 (1963-12-01), Hofmann et al.
patent: 3183234 (1965-05-01), Garbrecht
patent: 3228941 (1966-01-01), Barnardi et al.
patent: 3249617 (1966-05-01), Hofmann et al.
patent: 3580916 (1971-05-01), Garbrecht
patent: 4230859 (1980-10-01), Rucman
patent: 4321381 (1982-03-01), Mantegani et al.
Cohen et al, Journal of Pharmacology and Experimental Therapeutics, vol. 227, No. 21, pp. 327-332.
Cohen et al, Journal of Pharmacology and Experimental Therapeutics, vol. 232, No. 3, pp. 770-774.
Lemberger et al, Life Sciences; vol. 35, pp. 71-77.
Cohen et al, Drug Development Research 5:313-321 (1985).
Hingtgen et al, Abstracts, Society for Neuroscience 13th Annual Meeting, Nov. 6-11, 1983, p. 125.
Garbrecht William L.
Whitten Kathleen R.
Barclay Bruce J.
Daus Donald G.
Eli Lilly and Company
Shen Cecilia
Whitaker Leroy
LandOfFree
Phenacyl esters of 1-substituted-6-(substituted and unsubstitute does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenacyl esters of 1-substituted-6-(substituted and unsubstitute, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenacyl esters of 1-substituted-6-(substituted and unsubstitute will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1674534